Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity

View ORCID ProfileChantal B.F. Vogels, Anne E. Watkins, Christina A. Harden, Doug E. Brackney, Jared Shafer, Jianhui Wang, View ORCID ProfileCésar Caraballo, View ORCID ProfileChaney C. Kalinich, Isabel M. Ott, Joseph R. Fauver, Eriko Kudo, Peiwen Lu, Arvind Venkataraman, Maria Tokuyama, Adam J. Moore, M. Catherine Muenker, Arnau Casanovas-Massana, John Fournier, Santos Bermejo, Melissa Campbell, Rupak Datta, Allison Nelson, Yale IMPACT Research Team, Charles S. Dela Cruz, Albert I. Ko, View ORCID ProfileAkiko Iwasaki, Harlan M. Krumholz, JD Matheus, Pei Hui, Chen Liu, Shelli F. Farhadian, Robby Sikka, View ORCID ProfileAnne L. Wyllie, Nathan D. Grubaugh
doi: https://doi.org/10.1101/2020.08.03.20167791
Chantal B.F. Vogels
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chantal B.F. Vogels
  • For correspondence: chantal.vogels@yale.edu anne.wyllie@yale.edu nathan.grubaugh@yale.edu
Anne E. Watkins
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina A. Harden
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Doug E. Brackney
2Connecticut Agricultural Experimental Station, State of Connecticut, New Haven, CT, 06511 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jared Shafer
3Drug Free Sport International, Kansas City, MO 64108, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianhui Wang
4Department of Pathology, Yale University School of Medicine, New Haven, CT, 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
César Caraballo
5Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, 06510, USA
6Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for César Caraballo
Chaney C. Kalinich
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chaney C. Kalinich
Isabel M. Ott
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph R. Fauver
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eriko Kudo
7Department of Immunobiology, Yale University School of Medicine, New Haven, CT, 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peiwen Lu
7Department of Immunobiology, Yale University School of Medicine, New Haven, CT, 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arvind Venkataraman
7Department of Immunobiology, Yale University School of Medicine, New Haven, CT, 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Tokuyama
7Department of Immunobiology, Yale University School of Medicine, New Haven, CT, 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam J. Moore
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Catherine Muenker
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnau Casanovas-Massana
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Fournier
8Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Santos Bermejo
9Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa Campbell
8Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rupak Datta
8Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allison Nelson
8Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles S. Dela Cruz
9Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert I. Ko
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akiko Iwasaki
7Department of Immunobiology, Yale University School of Medicine, New Haven, CT, 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Akiko Iwasaki
Harlan M. Krumholz
5Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, 06510, USA
6Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JD Matheus
3Drug Free Sport International, Kansas City, MO 64108, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pei Hui
4Department of Pathology, Yale University School of Medicine, New Haven, CT, 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chen Liu
4Department of Pathology, Yale University School of Medicine, New Haven, CT, 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shelli F. Farhadian
8Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robby Sikka
10Minnesota Timberwolves, Minneapolis, MN, 55403 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne L. Wyllie
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anne L. Wyllie
  • For correspondence: chantal.vogels@yale.edu anne.wyllie@yale.edu nathan.grubaugh@yale.edu
Nathan D. Grubaugh
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: chantal.vogels@yale.edu anne.wyllie@yale.edu nathan.grubaugh@yale.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Current bottlenecks for improving accessibility and scalability of SARS-CoV-2 testing include diagnostic assay costs, complexity, and supply chain shortages. To resolve these issues, we developed SalivaDirect, which received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration on August 15th, 2020. The critical component of our approach is to use saliva instead of respiratory swabs, which enables non-invasive frequent sampling and reduces the need for trained healthcare professionals during collection. Furthermore, we simplified our diagnostic test by (1) not requiring nucleic acid preservatives at sample collection, (2) replacing nucleic acid extraction with a simple proteinase K and heat treatment step, and (3) testing specimens with a dualplex quantitative reverse transcription PCR (RT-qPCR) assay. We validated SalivaDirect with reagents and instruments from multiple vendors to minimize the risk for supply chain issues. Regardless of our tested combination of reagents and instruments from different vendors, we found that SalivaDirect is highly sensitive with a limit of detection of 6-12 SARS-CoV-2 copies/μL. When comparing SalivaDirect to paired nasopharyngeal swabs using the authorized ThermoFisher Scientific TaqPath COVID-19 combo kit, we found high agreement in testing outcomes (>94%). In partnership with the National Basketball Association (NBA) and Players Association, we conducted a large-scale (n = 3,779) SalivaDirect usability study and comparison to standard nasal/oral tests for asymptomatic and presymptomatic SARS-CoV-2 detection. From this cohort of healthy NBA players, staff, and contractors, we found that 99.7% of samples were valid using our saliva collection techniques and a 89.5% positive and >99.9% negative test agreement to swabs, demonstrating that saliva is a valid and noninvasive alternative to swabs for large-scale SARS-CoV-2 testing. SalivaDirect is a flexible and inexpensive ($1.21-$4.39/sample in reagent costs) option to help improve SARS-CoV-2 testing capacity. Register to become a designated laboratory to use SalivaDirect under our FDA EUA on our website: publichealth.yale.edu/salivadirect/.

Competing Interest Statement

ALW has received research funding through grants from Pfizer to Yale and has received consulting fees for participation in advisory boards for Pfizer. The other authors declare no competing interests.

Funding Statement

This study was funded by a clinical research agreement with the NBA and NBPA (NDG), the Huffman Family Donor Advised Fund (NDG), Fast Grant funding support from the Emergent Ventures at the Mercatus Center, George Mason University (NDG), the Yale Institute for Global Health (NDG), and the Beatrice Kleinberg Neuwirth Fund (AIK). CBFV is supported by NWO Rubicon 019.181EN.004.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional Review Board of the Yale Human Research Protection Program (Protocol IDs. 2000027690, 0409027018, and 2000028394)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data are included in this article, the supplementary files, and the Source Data.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 28, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity
Chantal B.F. Vogels, Anne E. Watkins, Christina A. Harden, Doug E. Brackney, Jared Shafer, Jianhui Wang, César Caraballo, Chaney C. Kalinich, Isabel M. Ott, Joseph R. Fauver, Eriko Kudo, Peiwen Lu, Arvind Venkataraman, Maria Tokuyama, Adam J. Moore, M. Catherine Muenker, Arnau Casanovas-Massana, John Fournier, Santos Bermejo, Melissa Campbell, Rupak Datta, Allison Nelson, Yale IMPACT Research Team, Charles S. Dela Cruz, Albert I. Ko, Akiko Iwasaki, Harlan M. Krumholz, JD Matheus, Pei Hui, Chen Liu, Shelli F. Farhadian, Robby Sikka, Anne L. Wyllie, Nathan D. Grubaugh
medRxiv 2020.08.03.20167791; doi: https://doi.org/10.1101/2020.08.03.20167791
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity
Chantal B.F. Vogels, Anne E. Watkins, Christina A. Harden, Doug E. Brackney, Jared Shafer, Jianhui Wang, César Caraballo, Chaney C. Kalinich, Isabel M. Ott, Joseph R. Fauver, Eriko Kudo, Peiwen Lu, Arvind Venkataraman, Maria Tokuyama, Adam J. Moore, M. Catherine Muenker, Arnau Casanovas-Massana, John Fournier, Santos Bermejo, Melissa Campbell, Rupak Datta, Allison Nelson, Yale IMPACT Research Team, Charles S. Dela Cruz, Albert I. Ko, Akiko Iwasaki, Harlan M. Krumholz, JD Matheus, Pei Hui, Chen Liu, Shelli F. Farhadian, Robby Sikka, Anne L. Wyllie, Nathan D. Grubaugh
medRxiv 2020.08.03.20167791; doi: https://doi.org/10.1101/2020.08.03.20167791

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (453)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (158)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5275)
  • Forensic Medicine (3)
  • Gastroenterology (197)
  • Genetic and Genomic Medicine (759)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (700)
  • Health Policy (361)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (164)
  • Infectious Diseases (except HIV/AIDS) (5904)
  • Intensive Care and Critical Care Medicine (363)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (769)
  • Nursing (43)
  • Nutrition (132)
  • Obstetrics and Gynecology (144)
  • Occupational and Environmental Health (234)
  • Oncology (481)
  • Ophthalmology (152)
  • Orthopedics (39)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2028)
  • Radiology and Imaging (350)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)